Correlation Between EPIRUS Biopharmaceutica and Mosaic Immunoengineerin

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EPIRUS Biopharmaceutica and Mosaic Immunoengineerin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EPIRUS Biopharmaceutica and Mosaic Immunoengineerin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EPIRUS Biopharmaceuticals and Mosaic Immunoengineering, you can compare the effects of market volatilities on EPIRUS Biopharmaceutica and Mosaic Immunoengineerin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EPIRUS Biopharmaceutica with a short position of Mosaic Immunoengineerin. Check out your portfolio center. Please also check ongoing floating volatility patterns of EPIRUS Biopharmaceutica and Mosaic Immunoengineerin.

Diversification Opportunities for EPIRUS Biopharmaceutica and Mosaic Immunoengineerin

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between EPIRUS and Mosaic is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding EPIRUS Biopharmaceuticals and Mosaic Immunoengineering in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosaic Immunoengineering and EPIRUS Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EPIRUS Biopharmaceuticals are associated (or correlated) with Mosaic Immunoengineerin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosaic Immunoengineering has no effect on the direction of EPIRUS Biopharmaceutica i.e., EPIRUS Biopharmaceutica and Mosaic Immunoengineerin go up and down completely randomly.

Pair Corralation between EPIRUS Biopharmaceutica and Mosaic Immunoengineerin

If you would invest  130.00  in Mosaic Immunoengineering on August 31, 2024 and sell it today you would lose (31.00) from holding Mosaic Immunoengineering or give up 23.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy8.08%
ValuesDaily Returns

EPIRUS Biopharmaceuticals  vs.  Mosaic Immunoengineering

 Performance 
       Timeline  
EPIRUS Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EPIRUS Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, EPIRUS Biopharmaceutica is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Mosaic Immunoengineering 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mosaic Immunoengineering are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting primary indicators, Mosaic Immunoengineerin showed solid returns over the last few months and may actually be approaching a breakup point.

EPIRUS Biopharmaceutica and Mosaic Immunoengineerin Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EPIRUS Biopharmaceutica and Mosaic Immunoengineerin

The main advantage of trading using opposite EPIRUS Biopharmaceutica and Mosaic Immunoengineerin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EPIRUS Biopharmaceutica position performs unexpectedly, Mosaic Immunoengineerin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosaic Immunoengineerin will offset losses from the drop in Mosaic Immunoengineerin's long position.
The idea behind EPIRUS Biopharmaceuticals and Mosaic Immunoengineering pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk